JV - Award for Best Belgian Sustainability Report

Department of ParasitologyPublications in international peer-reviewedjournals with impact factorAchan J, Tibenderana J, Kyabayinze D, Mawejje H, Mugizi R, Mpeka B,Talisuna A, D’Alessandro U. Case management of severe malaria - aforgotten practice: experiences from health facilities in Uganda. PLoSONE 2011;6(3):e17053.Achan J, Talisuna AO, Erhart A, Yeka A, Tibenderana JK, Baliraine FN,Rosenthal PJ, D’Alessandro U. Quinine, an old anti-malarial drug in amodern world: role in the treatment of malaria. Malar J 2011;10(144):1-12.Adaui V, Maes I, Huyse T, Van den Broeck F, Talledo M, Kuhls K, DeDoncker S, Maes L, Llanos-Cuentas A, Schönian G, Arevalo J, DujardinJC. Multilocus genotyping reveals a polyphyletic pattern amongnaturally antimony-resistant Leishmania braziliensis isolates from Peru.Infect Genet Evol 2011;11(8):1873-80.Adaui V, Castillo D, Zimic M, Gutierrez A, Decuypere S, VanaerschotM, De Doncker S, Schnorbusch K, Maes I, Van der Auwera G, MaesL, Llanos-Cuentas A, Arevalo J, Dujardin JC. Comparative geneexpression analysis throughout the life cycle of Leishmania braziliensis:diversity of expression profiles among clinical isolates. PLoS Negl TropDis 2011;5(5):e1021.Adaui V, Schnorbusch K, Zimic M, Gutiérrez A, Decuypere S,Vanaerschot M, De Doncker S, Maes I, Llanos-Cuentas A, Chappuis F,Arévalo J, Dujardin JC. Comparison of gene expression patterns amongLeishmania braziliensis clinical isolates showing a different in vitrosusceptibility to pentavalent antimony. Parasitology 2011;138(2):183-93.Aregawi MW, Ali AS, Al-Mafazy AW, Molteni F, Katikiti S, Warsame M,Njau RJA, Komatsu R, Korenromp E, Hosseini M, Low-Beer D, BjorkmanA, D’Alessandro U, Coosemans M, Otten M. Reductions in malaria andanaemia case and death burden at hospitals following scale-up ofmalaria control in Zanzibar, 1999-2008. Malar J 2011;10(46):1-9.de La Rocque S, Balenghien T, Halos L, Dietze K, Claes F, Ferrari G,Guberti V, Slingenbergh J. A review of trends in the distribution ofvector-borne diseases: is international trade contributing to theirspread? Rev Sci Tech Off Int Epizoot 2011;30(1):119-30.De Vooght L, Caljon G, Coosemans M, Van Den Abbeele J. Functionalanalysis of the twin-arginine translocation pathway in Sodalisglossinidius, a bacterial symbiont of the tsetse fly. Appl EnvironMicrobiol 2011;77(3):1132-4.Deborggraeve S, Lejon V, Ekangu RA, Mumba Ngoyi D, Pyana PP, IlungaM, Mulunda JP, Büscher P. Diagnostic accuracy of PCR in gambiensesleeping sickness diagnosis, staging and post-treatment follow-up: a2-year longitudinal study. PLoS Negl Trop Dis 2011;5(2):e972.Dekoninck W, Hendrickx F, Van Bortel W, Versteirt V, Coosemans M,Damiens D, Hance T, De Clercq EM, Hendrickx G, Schaffner F, GrootaertP. Human-induced expanded distribution of Anopheles plumbeus,experimental vector of West Nile virus and a potential vector of humanmalaria in Belgium. J Med Entomol 2011;48(4):924-8.Downing T, Imamura H, Decuypere S, Clark TG, Coombs GH, CottonJA, Hilley JD, De Doncker S, Maes I, Mottram JC, Quail MA, Rijal S,Sanders M, Schönian G, Stark O, Sundar S, Vanaerschot M, Hertz-Fowler C, Dujardin JC, Berriman M. Whole genome sequencing ofmultiple Leishmania donovani clinical isolates provides insights intopopulation structure and mechanisms of drug resistance. Genome Res2011;21(12):2143-56.Durnez L, Van Bortel W, Denis L, Roelants P, Veracx A, Trung HD,Sochantha T, Coosemans M. False positive circumsporozoite proteinELISA: a challenge for the estimation of the entomological inoculationrate of malaria and for vector incrimination. Malar J 2011;10(195):1-9.Gidwani K, Picado A, Ostyn B, Singh SP, Kumar R, Khanal B, Lejon V,Chappuis F, Boelaert M, Sundar S. Persistence of Leishmania donovaniantibodies in past visceral leishmaniasis cases in India. Clin VaccineImmunol 2011;18(2):346-8.Gillingwater K, Gutierrez C, Bridges A, Wu H, Deborggraeve S, EkanguRA, Kumar A, Ismail M, Boykin D, Brun R. Efficacy study of noveldiamidine compounds in a Trypanosoma evansi goat model. PLoS ONE2011;6(6):e20836.Hainard A, Tiberti N, Robin X, Ngoyi DM, Matovu E, Enyaru JC, Müller M,Turck N, Ndung’u JM, Lejon V, Sanchez JC. Matrix metalloproteinase-9and intercellular adhesion molecule 1 are powerful staging markers forhuman African trypanosomiasis. Trop Med Int Health 2011;16(1):119-26.Inocêncio da Luz R, Romero GAS, Dorval ME, Cruz I, CañavateC, Dujardin JC, Van Assche T, Cos P, Maes L. Drug susceptibilityof Leishmania infantum (syn. Leishmania chagasi) isolates fromBrazilian HIV-positive and HIV-negative patients [letter]. J AntimicrobChemother 2011;66(3):677-9.Kanobana K, Praet N, Kabwe C, Dorny P, Lukanu P, Madinga J, MitashiP, Verwijs M, Lutumba P, Polman K. High prevalence of Taenia soliumcysticerosis in a village community of Bas-Congo, Democratic Republicof Congo. Int J Parasitol 2011;41(10):1015-8.Killeen GF, Okumu FO, N’Guessan R, Coosemans M, Adeogun A,Awolola S, Etang J, Dabiré RK, Corbel V. The importance of consideringcommunity-level effects when selecting insecticidal malaria vectorcontrol products. Parasit Vectors 2011;4(160):1-7.Lubell Y, Staedke SG, Greenwood BM, Kamya MR, Molyneux M, NewtonPN, Reyburn H, Snow RW, D’Alessandro U, English M, Day N, KremsnerP, Dondorp A, Mbacham W, Dorsey G, Owusu-Agyei S, Maitland K,Krishna S, Newton C, Pasvol G, Taylor T, von Seidlein L, White NJ, BinkaF, Mills A, Whitty CJ. Likely health outcomes for untreated acute febrileillness in the tropics in decision and economic models; a delphi survey.PLoS ONE 2011;6(2):e17439.Marchal B, Van Dormael M, Pirard M, Cavalli A, Kegels G, PolmanK. Neglected tropical disease (NTD) control in health systems: theinterface between programmes and general health services. Acta Trop2011;120(Suppl. 1):S177-S185.Meurs L, Labuda L, Amoah AS, Mbow M, Ngoa UA, Boakye DA,Mboup S, Dièye TN, Mountford AP, Turner JD, Kremsner PG, PolmanK, Yazdanbakhsh M, Adegnika AA. Enhanced pro-inflammatorycytokine responses following toll-like-receptor ligation in Schistosomahaematobium-infected schoolchildren from rural Gabon. PLoS ONE2011;6(9):e24393.Migchelsen SJ, Büscher P, Hoepelman AIM, Schallig HDFH, Adams ER.Human African trypanosomiasis: a review of non-endemic cases in thepast 20 years. Int J Infect Dis 2011;15(8):e517-e524.Mukhopadhyay R, Mukherjee S, Mukherjee B, Naskar K, Mondal D,Decuypere S, Ostyn B, Prajapati VK, Sundar S, Dujardin JC, Roy S.Characterisation of antimony-resistant Leishmania donovani isolates:biochemical and biophysical studies and interaction with host cells.Int J Parasitol 2011;41(13-14):1311-21.Mumba D, Bohorquez E, Messina J, Kande V, Taylor SM, Tshefu AK,Muwonga J, Kashamuka MM, Emch M, Tidwell R, Büscher P, MeshnickSR. Prevalence of Human African Trypanosomiasis in the DemocraticRepublic of the Congo. PLoS Negl Trop Dis 2011;5(8):e1246.Nambozi M, Van geertruyden JP, Hachizovu S, Chaponda M,Mukwamataba D, Mulenga M, Ubben D, D’Alessandro U. Safetyand efficacy of dihydroartemisinin-piperaquine versus artemetherlumefantrinein the treatment of uncomplicated Plasmodiumfalciparum malaria in Zambian children. Malar J 2011;10(50):1-9.Odiwuor S, Vuylsteke M, De Doncker S, Maes I, Mbuchi M, DujardinJC, Van der Auwera G. Leishmania AFLP: paving the way towardsimproved molecular assays and markers of diversity. Infect Genet Evol2011;11(5):960-7.64 | ONDERZOEK